The sensitivity sub‐analysis among patients who underwent DDP + 5FU CT scheme for clinical stage III‐IV SCC confirmed that higher levels of PD‐L1 expression either on tumor cells or in lymphocytes and CD8+ T cells infiltration were observed in ypCR group than in yPPD group. The gene discussed is CD8A; the disease is neoplasm.